Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $113.2900 (-5.22%) ($113.0400 - $121.0000) on Tue. Dec. 4, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.41% (three month average) | RSI | 53 | Latest Price | $113.2900(-5.22%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(44%) IBB(43%) XBI(42%) VFMO(41%) VT(40%) | Factors Impacting UTHR price | UTHR will decline at least -1.205% in a week (0% probabilities). VXX(-14%) TLT(-14%) VIXM(-11%) UUP(-10%) DIA(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.205% (StdDev 2.41%) | Hourly BBV | 0 () | Intraday Trend | -6% | | | |
|
Resistance Level | $115.62 | 5 Day Moving Average | $117.19(-3.33%) | 10 Day Moving Average | $115.79(-2.16%) | 20 Day Moving Average | $115.62(-2.02%) | To recent high | -12% | To recent low | 2.2% | Market Cap | $5.025b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |